Leap Therapeutics Inc (NASDAQ:LPTX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - LPTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - LPTX

  • Market Cap$87.120m
  • SymbolNASDAQ:LPTX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS52187K1016

Company Profile

Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204, P205, and P103.Leap Therapeutics Inc is a biopharmaceutical company . The company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.

Latest LPTX news

Currently there for this company. Visit our news hub for other news .